These results suggest that the unique therapeutical possibility of IGF-I administration seem to be in conditions "with IGF-I deficiency" (as it is common with other hormones) although it is possible to see a direct action of IGF-I on testes in all conditions. The gene discussed is IGF1; the disease is hyperinsulinemic hypoglycemia, familial, 4.